Exact Sciences CEO: Aetna Decision Nothing to Worry About — Market Talk

16:36 EDT – Exact Sciences (EXAS) CEO Kevin Conroy isn’t discouraged by Aetna’s (AET) determination that EXAS’s new DNA test for colon cancer screening isn’t “medically necessary.” Conroy says in an interview that AET’s review was conducted prior to FDA approval, and won’t impact a pending…

Read more…

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s